184 related articles for article (PubMed ID: 15353533)
1. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial.
Talbot TR; Stapleton JT; Brady RC; Winokur PL; Bernstein DI; Germanson T; Yoder SM; Rock MT; Crowe JE; Edwards KM
JAMA; 2004 Sep; 292(10):1205-12. PubMed ID: 15353533
[TBL] [Abstract][Full Text] [Related]
2. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.
Hsieh SM; Chen SY; Sheu GC; Hung MN; Chou WH; Chang SC; Hsu KH
Vaccine; 2006 Jan; 24(4):510-5. PubMed ID: 16139395
[TBL] [Abstract][Full Text] [Related]
3. Response to smallpox vaccine in persons immunized in the distant past.
Frey SE; Newman FK; Yan L; Lottenbach KR; Belshe RB
JAMA; 2003 Jun; 289(24):3295-9. PubMed ID: 12824212
[TBL] [Abstract][Full Text] [Related]
4. Cellular immune responses to diluted and undiluted aventis pasteur smallpox vaccine.
Rock MT; Yoder SM; Talbot TR; Edwards KM; Crowe JE
J Infect Dis; 2006 Aug; 194(4):435-43. PubMed ID: 16845626
[TBL] [Abstract][Full Text] [Related]
5. Dose-related effects of smallpox vaccine.
Frey SE; Newman FK; Cruz J; Shelton WB; Tennant JM; Polach T; Rothman AL; Kennedy JS; Wolff M; Belshe RB; Ennis FA
N Engl J Med; 2002 Apr; 346(17):1275-80. PubMed ID: 11923489
[TBL] [Abstract][Full Text] [Related]
6. Clinical responses to undiluted and diluted smallpox vaccine.
Frey SE; Couch RB; Tacket CO; Treanor JJ; Wolff M; Newman FK; Atmar RL; Edelman R; Nolan CM; Belshe RB;
N Engl J Med; 2002 Apr; 346(17):1265-74. PubMed ID: 11923490
[TBL] [Abstract][Full Text] [Related]
7. Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses.
Couch RB; Winokur P; Edwards KM; Black S; Atmar RL; Stapleton JT; Kissner JM; Shinefield H; Denny TN; Bybel MJ; Newman FK; Yan L;
J Infect Dis; 2007 Mar; 195(6):826-32. PubMed ID: 17299712
[TBL] [Abstract][Full Text] [Related]
8. Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers.
Bossi P; Gay F; Fouzai I; Combadière B; Brousse G; Lebrun-Vignes B; Crance JM; Autran B; Garin D
PLoS One; 2008; 3(12):e4087. PubMed ID: 19116649
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent neutralizing-antibody responses to vaccinia.
Belshe RB; Newman FK; Frey SE; Couch RB; Treanor JJ; Tacket CO; Yan L
J Infect Dis; 2004 Feb; 189(3):493-7. PubMed ID: 14745707
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial.
Greenberg RN; Kennedy JS; Clanton DJ; Plummer EA; Hague L; Cruz J; Ennis FA; Blackwelder WC; Hopkins RJ
Lancet; 2005 Jan 29-Feb 4; 365(9457):398-409. PubMed ID: 15680454
[TBL] [Abstract][Full Text] [Related]
11. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.
Kim SH; Yeo SG; Jang HC; Park WB; Lee CS; Lee KD; Kim HB; Kim NJ; Kim YT; Jee Y; Cho H; Oh MD; Choe KW
J Infect Dis; 2005 Sep; 192(6):1066-70. PubMed ID: 16107961
[TBL] [Abstract][Full Text] [Related]
12. Focal and generalized folliculitis following smallpox vaccination among vaccinia-naive recipients.
Talbot TR; Bredenberg HK; Smith M; LaFleur BJ; Boyd A; Edwards KM
JAMA; 2003 Jun; 289(24):3290-4. PubMed ID: 12824211
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological comparison of smallpox vaccine administered to the outer versus the inner upper arms of vaccinia-naive adults.
Waibel KH; Golding H; Manischewitz J; King LR; Tuchscherer M; Topolski RL; Walsh DS
Clin Infect Dis; 2006 Feb; 42(4):e16-20. PubMed ID: 16421781
[TBL] [Abstract][Full Text] [Related]
14. Optimal bandaging of smallpox vaccination sites to decrease the potential for secondary vaccinia transmission without impairing lesion healing.
Talbot TR; Peters J; Yan L; Wright PF; Edwards KM
Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1184-92. PubMed ID: 17080375
[TBL] [Abstract][Full Text] [Related]
15. Clinical guidance for smallpox vaccine use in a postevent vaccination program.
Petersen BW; Damon IK; Pertowski CA; Meaney-Delman D; Guarnizo JT; Beigi RH; Edwards KM; Fisher MC; Frey SE; Lynfield R; Willoughby RE
MMWR Recomm Rep; 2015 Feb; 64(RR-02):1-26. PubMed ID: 25695372
[TBL] [Abstract][Full Text] [Related]
16. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for preventing smallpox.
Metzger W; Mordmueller BG
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD004913. PubMed ID: 17636779
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
Saito T; Fujii T; Kanatani Y; Saijo M; Morikawa S; Yokote H; Takeuchi T; Kuwabara N
JAMA; 2009 Mar; 301(10):1025-33. PubMed ID: 19278946
[TBL] [Abstract][Full Text] [Related]
19. A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults.
Artenstein AW; Johnson C; Marbury TC; Morrison D; Blum PS; Kemp T; Nichols R; Balser JP; Currie M; Monath TP
Vaccine; 2005 May; 23(25):3301-9. PubMed ID: 15837236
[TBL] [Abstract][Full Text] [Related]
20. [Verification of the safety, inoculability, reactogenicity and antigenic properties of a live recombinant smallpox-hepatitis B vaccine in an experiment in volunteers].
Chernos VI; Cheliapov NV; Antonova TP; Rakhilina LE; Unanov SS; Al'tshteĭn AD; Zakharova LG; Fodor II; Bendukidze KA; Komarov FI
Vopr Virusol; 1990; 35(2):132-5. PubMed ID: 2167564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
